Six-minute walking versus shuttle walking: Responsiveness to bronchodilation in chronic obstructive pulmonary disease

Thorax

Volumn 62, Issue 4, 2007, Pages 291-298

  Pepin, Véronique ^a   Brodeur, Julie ^a   Lacasse, Yves ^a   Milot, Julie ^a   LeBlanc, Pierre ^a   Whittom, François ^a   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE;

ADULT; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSPNEA; ENDURANCE; EXERCISE; FEMORAL NERVE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAGNETIC STIMULATION; MUSCLE FATIGUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMETRY; WALKING;

AGED; BICYCLING; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY; WALKING;

EID: 34147202259     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.065540     Document Type: Article

References (34)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2005.http://www.goldcopd.com.
2. Pepin V, Saey D, Whittom F, et al. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1517-22.
3. Saey D, Debigaré R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with COPD. Am J Respir Crit Care Med 2003;168:425-30.
4. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161:1897-901.
5. Mahler DA, Donohue JF, Barbee RA, et al. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999;115:957- 65.
6. Grove A, Lipworth BJ, Reid P, et al. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax 1996;51:689-93.
7. Boyd G, Morice AH, Pounsford JC, et al. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1997;10:815-21.
8. Hansen NC, May O. Domiciliary nebulized terbutaline in severe chronic airways obstruction. Eur Respir J 1990;3:463-4.
9. Mohammed AF, Anderson K, Matusiewicz SP, et al. Effect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstruction. Respir Med 1991;85:495-500.
10. 1, FVC, dyspnoea and walking distance in patients with chronic obstructive lung disease. Respir Med 1992;86:93-6.
11. Jaeschke R, Guyalt GH, Willan A, et al. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 1994;49:479-84.
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
13. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
14. Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24.
15. Revill SM, Morgan MD, Singh SJ, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
16. Guyalt GH, Pugsley S, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984;39:818-22.
17. ATS statement: guidelines lor the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
18. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81.
19. Jones B, Kenward MG. Design and analysis of cross-over trials, 2nd ed. New York: Chapman & Hall, 2003.
20. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14:270-4.
21. Troosters T, Vilaro J, Rabinovich R, et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;20:564-9.
22. Casas A, Vilaro J, Rabinovich R, et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005;128:55-61.
23. Connolly CK, Chan NS. Salbutamol and ipratropium in partially reversible airway obstruction. Br J Dis Chest 1987;81:55-61.
24. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992;5:659-64.
25. Spence DP, Hay JG, Carter J, et al. Oxygen desaruration and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax 1993;48:1145-50.
26. Eiser N, Willsher D, Dore CJ. Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir Med 2003;97:407-14.
27. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the six-minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997;155:1278-82.
28. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires, 2nd ed. New York: Oxford University Press, 1996.
29. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:562-7.
30. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-9.
31. Sciurba F, Criner GJ, Lee SM, et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003;167:1522-7.
32. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-9.
33. Eaton T, Young P, Nicol K, et al. The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients. Chronic Respir Dis 2006;3:3-9.
34. Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med 2006;173:865-70.